These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21195308)

  • 1. Graft versus leukemia reactivity after allogeneic stem cell transplantation.
    Falkenburg JH; Warren EH
    Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S33-8. PubMed ID: 21195308
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells.
    Troeger A; Meisel R; Moritz T; Dilloo D
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S59-64. PubMed ID: 15812533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allorecognition of the recipient after hematopoietic transplantation].
    Tiberghien P; Robinet E; Ferrand C; Saas P; Hervé P
    Bull Cancer; 2003; 90(8-9):706-10. PubMed ID: 14609760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.
    Sprangers B; Van Wijmeersch B; Fevery S; Waer M; Billiau AD
    Nat Clin Pract Oncol; 2007 Jul; 4(7):404-14. PubMed ID: 17597705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and enhancing the graft-versus-leukemia effect after hematopoietic stem cell transplantation.
    Molldrem J; Riddell S
    Cancer Treat Res; 2009; 144():187-208. PubMed ID: 19779869
    [No Abstract]   [Full Text] [Related]  

  • 8. [Graft vs. host disease and graft vs. leukemia/tumor effect].
    Okamoto S
    Nihon Rinsho; 2003 Sep; 61(9):1484-7. PubMed ID: 14515713
    [No Abstract]   [Full Text] [Related]  

  • 9. [Graft-versus-leukemia reactions].
    Ju X; Wang J
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):443-5. PubMed ID: 11721426
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic stem cell transplantation for chronic myeloid leukemia.
    Barrett J
    Semin Hematol; 2003 Jan; 40(1):59-71. PubMed ID: 12563612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy by allogeneic stem cell transplantation.
    Ringdén O
    Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
    Michallet M; Dhedin N; Michallet AS
    Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses.
    Reddy P; Maeda Y; Liu C; Krijanovski OI; Korngold R; Ferrara JL
    Nat Med; 2005 Nov; 11(11):1244-9. PubMed ID: 16227991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha interferon augments the graft-versus-leukaemia effect of second stem cell transplants and donor lymphocyte infusions in high-risk paediatric leukaemias.
    Cooper N; Rao K; Goulden N; Amrolia P; Veys P
    Br J Haematol; 2012 Feb; 156(4):550-2. PubMed ID: 21981646
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy].
    Michallet AS; Nicolini F; Michallet M
    Bull Cancer; 2003; 90(8-9):758-62. PubMed ID: 14609766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Interferon-gamma in GVHD and GVL.
    Yang YG; Wang H; Asavaroengchai W; Dey BR
    Cell Mol Immunol; 2005 Oct; 2(5):323-9. PubMed ID: 16368058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed graft versus leukemia effect after allogeneic peripheral stem cell transplantation in a patient with chronic lymphocytic leukemia.
    Gutiérrez A; Solano C; Prósper F; Benet I; Sarsotti E; García-Conde J
    Haematologica; 2000 Mar; 85(3):330-2. PubMed ID: 10702833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.